News and Resources
Statement of Phlow Corp. on the Introduction of the “PREPARE Act”
Phlow Corp. released the following statement on the introduction of S.2740, the Promoting Readiness and Ensuring Proper Active Pharmaceutical Ingredient Reserves of Essential Medicines (PREPARE) Act of 2021 in the United States Senate.
National Essential Medicine Shortage Awareness Day Highlights a Critical Public Health Issue that Demands America’s Attention
Phlow announces its support of the first annual National Essential Medicine Shortage Awareness Day. This observance was created to educate the public about the ongoing crisis of essential medicine shortages in the United States.
Observance Day Overview
September 8th has been identified as a national observance day to bring awareness to Americans of the need for reliable access to critical essential medicines. No American should ever be without the critical essential medicines necessary to sustain life and conquer disease.
The U.S. Needs to Reimagine Its Pharma Supply Chain
The pandemic has only exacerbated a previously existing problem: U.S. dependence on foreign manufacturers of drug ingredients and finished products that has resulted in shortages of critical medicines. The remedy is to create a domestic manufacturing capability, adopt new production technologies, and change what’s kept in the Strategic National Stockpile. This will require a partnership between the public and private sectors.
Phlow Corp. Receives The U.S Department of Health and Human Services, Office of Small and Disadvantaged Business Utilization, Small Business Prime Contractor of the Year Award
The U.S. Department of Health and Human Services (HHS), recently announced that Phlow Corp. has been awarded the Office of Small and Disadvantaged Business Utilization (OSDBU), Small Business Prime Contractor of the Year Award. Phlow Corp. is a U.S.-based, public benefit corporation committed to solving America’s broken essential medicine supply chain. This award recognizes Phlow for its performance during the previous fiscal year on its contract with HHS.
How Pharmaceutical Innovation is Transforming Petersburg
A surge of fresh energy and opportunities are attracting new residents and businesses to Virginia’s Gateway Region. Here’s what it means for the area – and why you might want to come along for the ride.
Phlow Corp. CFO Receives Virginia Business CFO Award
Phlow is honored to announce that our CFO, Bob Mooney, has received the coveted Virginia Business CFO Award honoring chief financial executives in Virginia.
Phlow Corporation Donates to Pleasants Lane Elementary in Petersburg
Phlow Corporation was honored to present, alongside our partners, AMPAC Fine Chemicals, Civica Rx, and Virginia Commonwealth University Medicines For All Institute, a check for over $58,000 on June 17, 2021 to Pleasants Lane Elementary in Petersburg, Virginia to rebuild their playground.
Phlow Corporation Supports Biden Administration Efforts to Strengthen the Pharmaceutical Supply Chain
The pieces of a Petersburg pharmaceuticals hub continue to fall into place.
Pharma Venture Fuels $25M Expansion of AMPAC Facility in Petersburg
The pieces of a Petersburg pharmaceuticals hub continue to fall into place.